R&D platforms

The microbial technology development platform, raw material technology development platform, and application technology development platform, relying on the leading synthetic biology and other technologies of the three major shareholders of Huadong Pharmaceutical, Angel Group, and Hunda Biology, quickly achieve the full industry chain research and development work of strain breeding, raw material separation and purification, quality research, pilot scale up, and application research, comprehensively solve customer needs, and empower partners.

R&D platforms

R&D capabilities

Magic Health's R&D technical team includes professionals from the three major industries of food, cosmetics, and medicine. Magic Health R&D Center, Angel Research Institute, and Hangzhou Synthetic Biology Industry Technology Research Institute focus on functional food and cosmetic raw materials, covering several major research directions such as basic research on raw materials, food field, cosmetics field, and synthetic biology. Providing customers with research and development support throughout the entire industry chain, from raw materials to terminals.

Industry university research cooperation

Magic Health collaborates with research institutions and universities such as the Ningbo Institute of Materials, Chinese Academy of Sciences, Dalian Institute of Chemical Physics, Taizhou Pharmaceutical City Guoke Chemical and Biopharmaceutical Technology Co., Ltd. (China Pharmaceutical City Biomedical Innovation Research Institute), and Zhejiang University of Technology in the fields of synthetic biology and applied technology. Magic Health looks forward to in-depth cooperation and exchange with research institutions from various countries.

Industry University Research Cooperation
Industry University Research Cooperation
Industry University Research Cooperation
Industry University Research Cooperation